Drugs / Inactivated Polio Vaccine

Trials 5

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 44 trials · 2 met primary
Phase 4 NCT04051736 Mar → Dec 2018 — China National Biotec Group Company Limited Completed Met primary
Phase 4 NCT01908114 Jul 2013 → Jul 2017 poliomyelitis Aga Khan University Unknown Met primary
Phase 4 NCT00893906 May 2009 → Dec 2012 influenza PATH Completed Mixed
Phase 4 NCT00168662 Mar 1995 → Jan 2006 measles Bandim Health Project Completed No outcome recorded
Phase not applicable1 trial
— NCT00137696 Jul 2003 → Jul 2004 poliomyelitis Centers for Disease Control and Prevention Completed No outcome recorded
Comparator or background therapy6 trials
Phase 2/3 NCT06947499 Comparator May 2025 → Feb 2028 expected diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +2 LG Chem Active not recruiting No outcome recorded
Phase 2/3 NCT01810731 Comparator Apr 2014 HIV infectious disease, influenza, malaria, poliomyelitis +1 Centers for Disease Control and Prevention Withdrawn No outcome recorded
Phase 3 NCT01813604 Comparator Nov 2012 → Nov 2013 poliomyelitis Centers for Disease Control and Prevention Completed No outcome recorded
Phase 4 NCT04998344 Comparator Apr 2021 → Dec 2024 influenza University of Bergen Unknown No outcome recorded
Phase 4 NCT03723837 Comparator Nov 2018 → Jun 2019 poliomyelitis Tribhuvan University Teaching Hospital, Institute Of Medicine. Completed No outcome recorded

News releases announcing trial results or a regulatory action · 2

DateIssuerRelease
2024-08-07 Sinovac Biotech Co., Ltd Results SINOVAC科兴灭活脊灰疫苗与其他疫苗同时接种安全有效 sinovac.com ↗
研究结果表明,无论是单独接种还是与其他疫苗同时接种, SINOVAC科兴的sIPV大规模应用于儿童基础免疫和加强免疫时,均具有良好的安全性和免疫原性。
2014-07-04 Daiichi Sankyo Regulatory Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) “Squarekids® subcutaneous injection syringe” daiichisankyo.com ↗

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 14 sources stand behind the page.

FieldValueCited text
Known as inactivated polio vaccine “introduction of inactivated polio vaccine (IPV) in combination with OPV” PMID 28495264 ↗ Jun 2017
10

NCT00893906 ↗

NCT01810731 ↗

NCT04998344 ↗

NCT01813604 ↗

NCT03723837 ↗

NCT00137696 ↗

NCT04051736 ↗

NCT00934245 ↗

NCT00168662 ↗

NCT06947499 ↗

Known as inactivated poliovirus vaccine “inactivated poliovirus vaccine (IPV)” NCT00934245 ↗
Known as IPV “Children born from September 1994 to January 1996 were randomized into two groups receiving either two doses of measles vaccine at 6 and 9 months or one dose of inactivated...” PMID 10342702 ↗ Apr 1999
6

“will be administered along with inactivated poliovirus vaccine (IPV) on first 3 visits in both cohorts” NCT00137696 ↗

“with either the 2008-09 northern hemisphere IIV3 or an inactivated polio vaccine (IPV).” PMID 30689757 ↗ Oct 2019

“introduction of inactivated polio vaccine (IPV) in combination with OPV” PMID 28495264 ↗ Jun 2017

“Inactivated polio vaccine (IPV)” NCT00934245 ↗

“inactivated polio vaccine (IPV)” NCT01813604 ↗

“Inactivated Polio Vaccine (IPV)” NCT03723837 ↗

Known as Sabin IPV “A domestic Sabin strain-based inactivated poliovirus vaccine (Sabin IPV) was approved by China Food and Drug Administration in 2017” PMID 33810904 ↗ Mar 2021
Modality Vaccine “inactivated polio vaccine” NCT00137696 ↗
Route Intramuscular “administered as a 0.5ml intramuscular or subcutaneous injection” NCT01810731 ↗
Route Subcutaneous “administered as a 0.5ml intramuscular or subcutaneous injection” NCT01810731 ↗